event recap
Innovations in rare cancers, according to leaders at AbbVie, Precigen and the Rare Cancer Research Foundation
Recent research has revealed that one in five cancers diagnosed in the U.S. is a rare cancer. Despite this alarming statistic, significant challenges remain in diagnosing and treating these diseases, as well as providing access to targeted therapies. Additionally, limited funding and clinical trials hinder the development of innovative solutions for rare cancers.
In a recent panel discussion …
Read more